Antidiuretic Drugs Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-06-24　·　250 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 2.12 Bn
2033 年預估規模: USD 3.41 Bn
年複合成長率 CAGR: 7%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-06-24頁數 250報告編號 CMI9685

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Antidiuretic Drugs Market, By Drug Type (Desmopressin, Vasopressin, Terlipressin, and Others), By Route of Administration (Oral, Injectable, and Intranasal), By Indication (Diabetes Insipidus, Nocturnal Enuresis (Bedwetting), Nocturia, Hemophilia A, Von Willebrand Disease, Vasodilatory Shock, and Others), By End User (Hospitals, Specialty Clinics, Homecare Settings, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global antidiuretic drugs market is estimated to be valued at USD 2.12 Bn in 2026 and is expected to reach USD 3.41 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7% from 2026 to 2033. The antidiuretic drugs market is a specific product segment of the endocrinology and nephrology pharmaceutical market, that focuses on the treatment with a therapeutic agent that controls water balance and minimizes urine production through the action that stimulates or substitutes antidiuretic hormone (ADH) hormone that can affect water balance. These include the treatment of central diabetes insipidus, nocturnal enuresis and also treat conditions such as the factor VIII related disorder hemophilia and von Willebrand’s disease. Increasing incidences in endocrine disorders and urological diseases and better diagnose of rare hormonal conditions are the main factors driving growth in this market. Growth in other therapeutic drug delivery methods such as oral, injection, intranasal delivery systems, along with growing studies of newer approaches based on vasopressin analogs and receptor targeting systems further boost the market in the future. Market Dynamics The global antidiuretic drugs market is driven by rising incidence of endocrine disorders like diabetes insipidus and nocturia, coupled with increasing need of long-term hormonal replacement therapies in the market. The market is also bolstered by rising awareness about rare hormonal disorders, increasing geriatric population in the market and advancements in formulations of intranasal and oral antidiuretic drugs. Further increasing research on drugs targeting the vasopressin receptor continue to offer newer treatments and improved results for the patients suffering from the diseases. However, a number of constraints are present in the market, such as hyponatremia, coupled with stringent regulations on hormonal medicines. Also, increasing drug approvals and stringent guidelines around the world are limiting product launches. Also, patent expirations and threat from new market players with their generic products also contributes to the limitations in the market. Nevertheless, researchers’ growing emphasis on investigating vasopressin-based treatments for critical care and neurological ailments are expected to provide lucrative opportunities for the market participants. Key Features of the Study • This report provides in-depth analysis of the global antidiuretic drugs market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global antidiuretic drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Ferring Pharmaceuticals, Amphastar Pharmaceuticals, Pfizer Inc., Endo International plc, Sun Pharmaceutical Industries Ltd., Cipla Limited, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, and Aurobindo Pharma Limited • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global antidiuretic drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antidiuretic drugs market Market Segmentation • Drug Type Insights (Revenue, USD Bn, 2021 - 2033) o Desmopressin o Vasopressin o Terlipressin o Others • Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) o Oral o Injectable o Intranasal • Indication Insights (Revenue, USD Bn, 2021 - 2033) o Diabetes Insipidus o Nocturnal Enuresis (Bedwetting) o Nocturia o Hemophilia A o Von Willebrand Disease o Vasodilatory Shock o Others • End User Insights (Revenue, USD Bn, 2021 - 2033) o Hospitals o Specialty Clinics o Homecare Settings o Others • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Ferring Pharmaceuticals o Amphastar Pharmaceuticals o Pfizer Inc. o Endo International plc o Sun Pharmaceutical Industries Ltd. o Cipla Limited o Teva Pharmaceutical Industries Ltd. o Reddy's Laboratories Ltd. o Hikma Pharmaceuticals PLC o Aurobindo Pharma Limited

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Antidiuretic Drugs Market, By Drug Type  Global Antidiuretic Drugs Market, By Route of Administration  Global Antidiuretic Drugs Market, By Indication  Global Antidiuretic Drugs Market, By End User  Global Antidiuretic Drugs Market, By Distribution Channel  Global Antidiuretic Drugs Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Industry Trends 4. Global Antidiuretic Drugs Market, By Drug Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Desmopressin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Vasopressin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Terlipressin  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Antidiuretic Drugs Market, By Route of Administration, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Injectable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Intranasal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Antidiuretic Drugs Market, By Indication, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Diabetes Insipidus  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Nocturnal Enuresis (Bedwetting)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Nocturia  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Hemophilia A  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Von Willebrand Disease  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Vasodilatory Shock  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Antidiuretic Drugs Market, By End User, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospitals  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Specialty Clinics  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Homecare Settings  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Antidiuretic Drugs Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 9. Global Antidiuretic Drugs Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Drug Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 10. Competitive Landscape o Ferring Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Amphastar Pharmaceuticals  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Pfizer Inc.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Endo International plc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sun Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Cipla Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Teva Pharmaceutical Industries Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Reddy's Laboratories Ltd.  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hikma Pharmaceuticals PLC  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Aurobindo Pharma Limited  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 11. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 12. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on ‘Antidiuretic Drugs Market' - Global forecast to 2033

提及公司

Ferring PharmaceuticalsAmphastar PharmaceuticalsPfizer Inc.Endo International plcSun Pharmaceutical Industries Ltd.Cipla LimitedTeva Pharmaceutical Industries Ltd.Reddy's Laboratories Ltd.Hikma Pharmaceuticals PLCAurobindo Pharma Limited

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們